Genetic Evidence for Causal Associations of Sarcopenia with Cardiometabolic Disease and Alzheimer's Disease and the Mediating Role of Insulin Resistance
Chaojie Ye,Lijie Kong,Yiying Wang,Min Xu,Jie Zheng,Yu Xu,Mian Li,Zhiyun Zhao,Jieli Lu,Yuhong Chen,Weiqing Wang,Guang Ning,Yufang Bi,Tiange Wang
DOI: https://doi.org/10.2139/ssrn.4196965
2022-01-01
SSRN Electronic Journal
Abstract:Background: The causal influence of sarcopenia on major cardiometabolic diseases and Alzheimer’s disease and whether and to what extent insulin resistance plays a mediation role remains unclear.Methods: We performed two-step, two-sample Mendelian randomization analyses, applying genetic instruments of grip strength, appendicular lean mass [ALM], and whole body lean mass [WBLM] from genome-wide association studies (GWASs) in UK Biobank (up to 461,026 participants) to examine their causal associations with six cardiometabolic diseases and Alzheimer’s disease extracted from reliable European-descent GWASs and to assess the proportions of the causal effects mediated by insulin resistance. Insulin resistance was estimated by fasting insulin based on GWAS from the Meta-Analyses of Glucose and Insulin-related traits Consortium (151,013 European participants).Findings: Each 1-SD lower genetically determined grip strength, ALM, and WBLM were associated with higher risks of diabetes (20%-57%), non-alcoholic fatty liver disease [NAFLD] (33%-130%), hypertension (12%-32%), coronary heart disease [CHD] (20%-42%), myocardial infarction [MI] (18%-45%), small vessel stroke (25%-29%), and Alzheimer’s disease (10%-28%). Insulin resistance mediated 10%-25% of the effect of grip strength and 7%-28% of the effect of ALM on diabetes, NAFLD, hypertension, CHD, and MI. The direct effect of WBLM on diabetes diminished towards null with adjustment for insulin resistance. The robustness of all causal findings from the random-effect inverse-variance weighted method was validated by several sensitivity analyses.Interpretation: Sarcopenia, measured by low muscle strength and muscle mass, was causally associated with higher risks of major cardiometabolic diseases and Alzheimer’s disease, with insulin resistance mediating a substantial proportion of sarcopenia-related cardiometabolic risk.Funding Information: This work was supported by the grants from the National Natural Science Foundation of China (82022011, 81970706, 82088102, 81970728, 81941017), the Chinese Academy of Medical Sciences (2018PT32017, 2019PT330006), the “Shanghai Municipal Education Commission–Gaofeng Clinical Medicine Grant Support” from Shanghai Jiao Tong University School of Medicine (20171901 Round 2), the Shanghai Shenkang Hospital Development Center (SHDC12019101, SHDC2020CR1001A, SHDC2020CR3064B), the Shanghai Jiao Tong University School of Medicine (DLY201801), and the Ruijin Hospital (2018CR002).Declaration of Interests: The authors declare no competing interests.Ethics Approval Statement: All the summary-level genome-wide association study (GWAS) data used in the analyses are publicly available, and therefore ethical approval was not imperative for this study. Ethical approval for the GWASs can be found in the corresponding GWAS publications cited in the manuscript.